NeoGenomics’ PanTracer LBx Receives Medicare Coverage, Expanding Access to Comprehensive Liquid Biopsy Profiling
Go back to NeoGenomics’ PanTracer LBx Receives Medicare Coverage, Expanding Access to Comprehensive Liquid Biopsy Profiling| NEOGENOMICS (NASDAQ: NEO) | Delayed: 15.16 +0.19 (1.27%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $14.97 | 52 Week High | $9.54 | |||
| Open | $15.00 | 52 Week Low | $5.49 | |||
| Day High | $15.56 | P/E | 379.00 | |||
| Day Low | $15.00 | EPS | $0.04 | |||
| Volume | 2,179,064 | |||||

